查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
聚合□鏈反應市場規模、份額和趨勢分析報告：按類型（常規 PCR）、按產品（儀器、耗材/試劑、軟件/服務）、按應用、按地區、按細分市場、預測 2022-2030 年
市場調查報告書
商品編碼
1114090

聚合□鏈反應市場規模、份額和趨勢分析報告：按類型（常規 PCR）、按產品（儀器、耗材/試劑、軟件/服務）、按應用、按地區、按細分市場、預測 2022-2030 年

Polymerase Chain Reaction Market Size, Share & Trends Analysis Report By Type (Conventional PCR), By Product (Instruments, Consumables & Reagents, Software & Services), By Application, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10個工作天內

價格

聚合□鍊式反應市場增長和趨勢

Grand View Research, Inc. 的一份新報告顯示，到 2030 年，全球聚合□鍊式反應市場預計將達到 184.4 億美元。

預計從 2022 年到 2030 年，複合年增長率為 7.5%。對聚合□鍊式反應 (PCR) 測試的需求將受到對先進診斷技術的需求增加、法醫和研究應用的增加以及慢性病、傳染病和遺傳病等疾病的日益流行的推動。基因檢測需求的增加和新技術的引入也是推動 PCR 檢測需求增加的主要因素。

由於先進診斷測試越來越多地採用以及 PCR 技術在醫療和非醫療應用中越來越多地採用等因素，預計該市場將出現增長機會。此外，新技術的推出、CRO 的增加以及研究機構和法醫實驗室的增加預計將在預測期內推動需求向前發展。多個研究機構和 CRO 正在開展基於基因組學的研究，以製定疾病管理的創新策略。

引進新技術和技術先進的檢查正在創造新的增長機會。例如，2021 年 1 月，GeneIQ 宣布推出 4 合 1 PCR 檢測，檢測乙型流感 (Flu B)、甲型流感 (Flu A)、呼吸道合胞病毒 (RSV) 和 SARS-CoV-2。同樣，2020 年 12 月，美納裡尼診斷公司推出了一項用於區分流感和 SARS-CoV-2 的分子檢測。這些努力將增加對新型 PCR 測試的需求。

政府機構實施的有利舉措正在推動參與者開髮用於各種應用的新型分子測試。例如，2020 年 1 月，在歐盟/EFPIA 創新藥物倡議聯合承諾下，赫爾辛基大學與歐盟合作，資助了一項評估 qPCR 以進行微生物群分析的研究。在本研究中，使用 iCycler iQ 熱循環儀系統和 HOT FIREPol EvaGreen qPCR Mix Plus 對梭菌簇 XIVa 進行了研究。此外，2020 年 3 月，國際原子能機構 (IAEA) 宣布與聯合國糧食及農業組織 (FAO) 建立合作夥伴關係，以支持使用逆轉錄 PCR。

一些公司正在採取收購等戰略來鞏固自己的地位。收購有助於加強公司的產品供應、能力和競爭力。例如，2021 年 1 月，賽默飛世爾科技宣布以 4.5 億美元收購分子診斷公司 Mesa Biotech，以加強其產品組合。因此，預計公司採用的各種策略將在預測期內推動需求向前發展。

聚合□鍊式反應市場報告亮點

2021 年，由於 PCR 在臨床診斷和藥物開發和研究中的應用越來越多，醫療應用主導了市場。

耗材和試劑產品部門預計將在 2021 年佔據最大的收入份額，並在預測期內保持其主導地位

由於存在有利的法規以及政府實施的有關醫療保健基礎設施進步的各種舉措以及該地區疾病的高流行率，北美在 2021 年主導了市場。

內容

第1章調查方法及範圍

  • 市場細分
    • 段範圍
    • 區域範圍
    • 估計/預測時間表
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • Gvr 內部數據庫
    • 輔助信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法 1：商品流通方法
      • 方法 2：使用自下而上的方法估算國別市場
      • 方法 3：使用自上而下的方法估算各國市場
  • 全球市場：CAGR 計算
  • 調查假設
  • 主要 KoL 回應
  • 市場份額的計算
  • 輔助信息列表
  • 目的
  • 縮寫列表

第 2 章執行摘要

  • 市場概覽

第 3 章 PCR 市場 - 行業展望

  • 市場系列展望
    • 母市場譜系預測
    • 相關/子公司市場展望
  • 繪製滲透率和增長前景
  • 市場動態
    • 市場驅動力
      • 慢性病、傳染病和遺傳病的發病率不斷上升
      • PCR技術進展
      • MIQE 指南的實施
      • 對快速診斷檢測的需求不斷增加，PCR 技術的採用率越來越高
      • 增加 CRO 以及法醫和調查機構的數量
      • 對產前基因檢測程序的需求不斷增加
      • COVID-19 爆發
    • 市場約束分析
      • qPCR 設備成本高
      • 嚴格的監管政策
  • 按因素（政治和法律、經濟和技術）進行 SWOT 分析
  • 行業分析 - 搬運工
  • 報銷和監管方案
  • 重大交易和戰略聯盟
    • 推出新產品
    • 獲取
    • 擴展名
    • 合作夥伴關係
    • 營銷和推廣
      • 市場進入策略
    • 分析未滿足的需求
      • 快速診斷的必要性
      • 實惠的價格
      • 病原體檢測範圍有限
    • 新 PCR 設備推出後市場動態的變化
      • 醫藥
      • 非醫療
    • 現有 PCR 和等離子 PCR 的比較
      • COVID-19 的可能性
    • 消費者行為分析

第 4 章 PCR 市場分析：Typescope，2018-2030 年（收入，百萬美元）

  • PCR 市場：類型變異分析
  • 常規 PCR
  • 其他

第 5 章 PCR 市場分析：2018-2030 年產品範圍（收入，百萬美元）

  • PCR 市場：產品變異分析
  • 消耗品和試劑
  • 儀器
  • 軟件和服務

第 6 章 PCR 市場分析：2018-2030 年範圍（收入，百萬美元）

  • PCR 市場：應用變異分析
  • 醫藥
    • 臨床
      • 病原體檢測
      • 腫瘤科檢查
      • 血液篩查
      • 其他
    • 調查
    • 取證等
  • 非醫療
    • 食物
    • 其他

第 7 章 PCR 市場分析，區域範圍，2018-2030，（收入，百萬美元）

  • 2021 年和 2030 年按國家/地區分列的市場份額分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 法國
      • 意大利
      • 西班牙
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 澳大利亞
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中東和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國

第 8 章 PCR 市場：競爭分析

  • 主要市場參與者的近期趨勢和影響分析
    • 安索夫矩陣`
  • 公司分類
    • 創新者
      • 市場差異化因素
  • 供應商情況
    • 主要分銷商和渠道合作夥伴列表
    • 主要客戶
    • 2021 年主要參與者的市場份額分析
  • 上市公司
    • 競爭信息中心分析
  • 私人公司
    • 主要初創企業列表
  • 本地網絡地圖
  • PCR 耗材/□在日本、澳大利亞、韓國、印度、新加坡和歐洲的主要區域/區域競爭對手
  • 公司簡介
    • 雅培
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • QIAGEN
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • BIO-RAD 實驗室, INC.
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 安捷倫科技公司
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Thermo Fisher Scientific, Inc.
      • 公司簡介
      • Affymetrix
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • CYTIVA（GE 醫療保健）
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • BIOMERIEUX SA
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • F. HOFFMANN-LA ROCHE LTD.
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 流體公司
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 斯蒂拉
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • MICROSYNTH AG
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • JN MEDSYS
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • 丹納赫公司
      • 公司簡介
      • 造父變
      • 貝克曼庫爾特
      • 徠卡生物系統
      • 財務表現
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68039-188-0

Polymerase Chain Reaction Market Growth & Trends:

The global polymerase chain reaction market size is expected to reach USD 18.44 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.5% from 2022 to 2030. The demand for polymerase chain reaction (PCR) testing is expected to be driven by the increasing demand for advanced diagnostic techniques; rising forensic and research applications; and the growing prevalence of diseases such as chronic diseases, infectious diseases, and genetic disorders. Moreover, increasing demand for genetic testing procedures and the introduction of novel technologies are other key factors likely to increase the demand for PCR testing.

The market is expected to witness growth opportunities owing to factors such as the increasing adoption of advanced diagnostic tests and the growing adoption of PCR technologies in medical and non-medical applications. Moreover, the launch of novel technologies, an increasing number of CROs, and research and forensic laboratories are expected to propel the demand forward during the forecast period. Several research institutes and CROs are involved in genomics-based research to develop innovative strategies for disease management.

The introduction of novel and technologically advanced tests is opening new growth opportunities. For instance, in January 2021, GeneIQ announced the launch of its 4-in-1 PCR test for the detection of influenza B (Flu B), influenza A (Flu A), respiratory syncytial virus (RSV), and SARS-CoV-2. Similarly, in December 2020, Menarini Diagnostics launched a molecular test that is used to distinguish between Flu and SARS-CoV-2. Such initiatives will increase the demand for novel PCR tests.

Favorable initiatives undertaken by government bodies are encouraging the players to develop novel molecular tests for different applications. For instance, in January 2020, the University of Helsinki in collaboration with the European Union under the EU/EFPIA Innovative Medicines Initiative Joint Undertaking, funded research for the assessment of qPCR for microbiota profiling. In the study, the iCycler iQ thermal cycler system was used with HOT FIREPol EvaGreen qPCR Mix Plus for studying Clostridium cluster XIVa. Moreover, in March 2020, International Atomic Energy Agency (IAEA) announced a partnership with the Food and Agriculture Organization of the United Nations (FAO) for supporting the use of reverse transcription-PCR.

Several companies are adopting strategies such as acquisitions for strengthening their positions. Acquisition assists companies to enhance their offerings, capabilities, and competencies. For instance, in January 2021, Thermo Fisher Scientific, Inc. announced that it has acquired Mesa Biotech, Inc. - a molecular diagnostic company for USD 450 million to strengthen its product portfolio. Thus, various strategies adopted by companies are anticipated to propel the demand forward over the forecast period.

Polymerase Chain Reaction Market Report Highlights:

  • In 2021, the medical application segment dominated the market owing to the rising application of PCR in clinical diagnostics and drug development and research
  • The consumables and reagents product segment held the largest revenue share in 2021 and is expected to retain its dominance over the forecast period
  • North America dominated the market in 2021 due to the presence of favorable regulations and various initiatives about the advancements in healthcare infrastructure undertaken by the government and the high prevalence of diseases in the region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
      • 1.6.1.3 Approach 3: Country-wise market estimation using top-down approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 Key KoL Responses
  • 1.10 Market Share Calculations
  • 1.11 List of Secondary Sources
  • 1.12 Objectives
    • 1.12.1 Objective 1:
    • 1.12.2 Objective 2:
  • 1.13 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 PCR Market - Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Rising incidence of chronic diseases, infectious diseases, and genetic disorders
      • 3.3.1.2 Technological advancements in PCR
      • 3.3.1.3 Implementation of MIQE guidelines
      • 3.3.1.4 Increasing demand for rapid diagnostic tests and growing adoption of PCR technologies
      • 3.3.1.5 Increasing number of CROs and forensic & research laboratories
      • 3.3.1.6 Increasing demand for prenatal genetic testing procedures
      • 3.3.1.7 Outbreak of COVID-19
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 High qPCR device costs
      • 3.3.2.2 Stringent regulatory policies
  • 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions
      • 3.7.5.1 Market entry strategies
    • 3.7.6 Unmet Need Analysis
      • 3.7.6.1 Need for rapid diagnosis
      • 3.7.6.2 Affordability
      • 3.7.6.3 Limited scope of pathogen detection
    • 3.7.7 Change In Market Dynamics After The Launch Of Novel PCR Devices
      • 3.7.7.1 Medical
      • 3.7.7.2 Non-Medical
    • 3.7.8 Comparison Of Existing PCR With Plasmonic PCR
      • 3.7.8.1 Potential for COVID-19
    • 3.7.9 Consumer Behavior Analysis

Chapter 4 PCR Market Analysis: Type Scope, 2018 - 2030 (Revenue, USD Million)

  • 4.1 PCR Market: Type Movement Analysis
  • 4.2 Conventional PCR
    • 4.2.1 Conventional PCR Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.3 Others
    • 4.3.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 PCR Market Analysis: Product Scope, 2018 - 2030 (Revenue, USD Million)

  • 5.1 PCR Market: Product Movement Analysis
  • 5.2 Consumables & Reagents
    • 5.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Instruments
    • 5.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Software & Services
    • 5.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 PCR Market Analysis: Application Scope, 2018 - 2030 (Revenue, USD Million)

  • 6.1 PCR Market: Application Movement Analysis
  • 6.2 Medical
    • 6.2.1 Medical Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Clinical
    • 6.2.3 Clinical Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.3.1 Pathogen Testing
      • 6.2.3.1.1 Pathogen Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.3.2 Oncology Testing
      • 6.2.3.2.1 Oncology Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.3.3 Blood Screening
      • 6.2.3.3.1 Blood Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.3.4 Others
      • 6.2.3.4.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.4 Research
      • 6.2.4.1 Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.5 Forensics And Others
      • 6.2.5.1 Forensics and other market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3 Non-medical
    • 6.3.1 Non-Medical Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2 Food
      • 6.3.2.1 Food Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.3 Others
      • 6.3.3.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 PCR Market Analysis, Regional Scope, 2018 - 2030, (Revenue, USD Million)

  • 7.1 Market Share Analysis by Country, 2021 & 2030
    • 7.1.1 North America
      • 7.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.1.2 U.S.
      • 7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.1.3 Canada
      • 7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.1.2 Europe
      • 7.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.2 U.K.
      • 7.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.3 Germany
      • 7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.4 France
      • 7.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.5 Italy
      • 7.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.6 Spain
      • 7.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.1.3 Asia Pacific
      • 7.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.2 Japan
      • 7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.3 China
      • 7.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.4 India
      • 7.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.5 South Korea
      • 7.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.6 Australia
      • 7.1.3.6.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.1.4 Latin America
      • 7.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.4.2 Brazil
      • 7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.4.3 Mexico
      • 7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.4.4 Argentina
      • 7.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.1.5 Middle East And Africa
      • 7.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.5.2 South Africa
      • 7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.5.3 Saudi Arabia
      • 7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.5.4 UAE
      • 7.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 PCR Market: Competitive Analysis

  • 8.1 Recent Developments and Impact Analysis, by Key Market Participants
    • 8.1.1 Ansoff Matrix`
  • 8.2 Company Categorization
    • 8.2.1 Innovators
      • 8.2.1.1 Market Differentiators
  • 8.3 Vendor Landscape
    • 8.3.1 List Of Key Distributors And Channel Partners
    • 8.3.2 Key Customers
    • 8.3.3 Key Company Market Share Analysis, 2021
  • 8.4 Public Companies
    • 8.4.1 Competitive Dashboard Analysis
  • 8.5 Private Companies
    • 8.5.1 List Of Key Emerging Companies
  • 8.6 Regional Network Map
  • 8.7 Key Regional/Local Competitors for PCR Consumables/Enzymes in Japan, Australia, Korea, India, Singapore, and Europe
  • 8.8 Company Profiles
    • 8.8.1 ABBOTT
      • 8.8.1.1 Company overview
      • 8.8.1.2 Financial performance
      • 8.8.1.3 Product benchmarking
      • 8.8.1.4 Strategic initiatives
    • 8.8.2 QIAGEN
      • 8.8.2.1 Company overview
      • 8.8.2.2 Financial performance
      • 8.8.2.3 Product benchmarking
      • 8.8.2.4 Strategic initiatives
    • 8.8.3 BIO-RAD LABORATORIES, INC.
      • 8.8.3.1 Company overview
      • 8.8.3.2 Financial performance
      • 8.8.3.3 Product benchmarking
      • 8.8.3.4 Strategic initiatives
    • 8.8.4 AGILENT TECHNOLOGIES, INC.
      • 8.8.4.1 Company overview
      • 8.8.4.2 Financial performance
      • 8.8.4.3 Product benchmarking
      • 8.8.4.4 Strategic initiatives
    • 8.8.5 THERMO FISHER SCIENTIFIC, INC.
      • 8.8.5.1 Company overview
      • 8.8.5.2 Affymetrix
      • 8.8.5.3 Company overview
      • 8.8.5.4 Financial performance
      • 8.8.5.5 Product benchmarking
      • 8.8.5.6 Strategic initiatives
    • 8.8.6 CYTIVA (GE HEALTHCARE)
      • 8.8.6.1 Company overview
      • 8.8.6.2 Financial performance
      • 8.8.6.3 Product benchmarking
      • 8.8.6.4 Strategic initiatives
    • 8.8.7 BIOMERIEUX SA
      • 8.8.7.1 Company overview
      • 8.8.7.2 Financial performance
      • 8.8.7.3 Product benchmarking
      • 8.8.7.4 Strategic initiatives
    • 8.8.8 F. HOFFMANN-LA ROCHE LTD.
      • 8.8.8.1 Company overview
      • 8.8.8.2 Financial performance
      • 8.8.8.3 Product benchmarking
      • 8.8.8.4 Strategic initiatives
    • 8.8.9 FLUIDIGM CORPORATION
      • 8.8.9.1 Company overview
      • 8.8.9.2 Financial performance
      • 8.8.9.3 Product benchmarking
      • 8.8.9.4 Strategic initiatives
    • 8.8.10 STILLA
      • 8.8.10.1 COMPANY OVERVIEW
      • 8.8.10.2 Product benchmarking
      • 8.8.10.3 Strategic initiatives
    • 8.8.11 MICROSYNTH AG
      • 8.8.11.1 Company overview
      • 8.8.11.2 Product benchmarking
      • 8.8.11.3 Strategic initiatives
    • 8.8.12 JN MEDSYS
      • 8.8.12.1 Company overview
      • 8.8.12.2 Product benchmarking
      • 8.8.12.3 Strategic initiatives
    • 8.8.13 DANAHER CORPORATION
      • 8.8.13.1 Company overview
      • 8.8.13.2 Cepheid
      • 8.8.13.3 Beckman Coulter
      • 8.8.13.4 Leica Biosystems
      • 8.8.13.5 Financial performance
      • 8.8.13.6 Product benchmarking
      • 8.8.13.7 Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 Incidence of diseases
  • Table 4 EUA (Emergency Use Authorization) PCR tests for COVID-19
  • Table 5 EUA (Emergency Use Authorization) molecular diagnostics tests for COVID-19 in 2021
  • Table 6 Comparison of existing PCR with Plasmonic PCR
  • Table 7 Real-time RT-PCR kits with EUA for COVID-19
  • Table 8 PCR systems with EUA for COVID-19
  • Table 9 North America PCR market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America PCR market, by type, 2018 - 2030 (USD Million)
  • Table 11 North America PCR market, by product, 2018 - 2030 (USD Million)
  • Table 12 North America PCR market, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. PCR market, by type, 2018 - 2030 (USD Million)
  • Table 14 U.S. PCR market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. PCR market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada PCR market, by type, 2018 - 2030 (USD Million)
  • Table 17 Canada PCR market, by product, 2018 - 2030 (USD Million)
  • Table 18 Canada PCR market, by application, 2018 - 2030 (USD Million)
  • Table 19 Europe PCR market, by Country, 2018 - 2030 (USD Million)
  • Table 20 Europe PCR market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe PCR market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe PCR market, by application, 2018 - 2030 (USD Million)
  • Table 23 U.K. PCR market, by type, 2018 - 2030 (USD Million)
  • Table 24 U.K. PCR market, by product, 2018 - 2030 (USD Million)
  • Table 25 U.K. PCR market, by application, 2018 - 2030 (USD Million)
  • Table 26 Germany PCR market, by type, 2018 - 2030 (USD Million)
  • Table 27 Germany PCR market, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany PCR market, by application, 2018 - 2030 (USD Million)
  • Table 29 France PCR market, by type, 2018 - 2030 (USD Million)
  • Table 30 France PCR market, by product, 2018 - 2030 (USD Million)
  • Table 31 France PCR market, by application, 2018 - 2030 (USD Million)
  • Table 32 Italy PCR market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy PCR market, by product, 2018 - 2030 (USD Million)
  • Table 34 Italy PCR market, by application, 2018 - 2030 (USD Million)
  • Table 35 Spain PCR market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain PCR market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain PCR market, by application, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific PCR market, by Country, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific PCR market, by type, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific PCR market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific PCR market, by application, 2018 - 2030 (USD Million)
  • Table 42 Japan PCR market, by type, 2018 - 2030 (USD Million)
  • Table 43 Japan PCR market, by product, 2018 - 2030 (USD Million)
  • Table 44 Japan PCR market, by application, 2018 - 2030 (USD Million)
  • Table 45 China PCR market, by type, 2018 - 2030 (USD Million)
  • Table 46 China PCR market, by product, 2018 - 2030 (USD Million)
  • Table 47 China PCR market, by application, 2018 - 2030 (USD Million)
  • Table 48 India PCR market, by type, 2018 - 2030 (USD Million)
  • Table 49 India PCR market, by product, 2018 - 2030 (USD Million)
  • Table 50 India PCR market, by application, 2018 - 2030 (USD Million)
  • Table 51 Australia PCR market, by type, 2018 - 2030 (USD Million)
  • Table 52 Australia PCR market, by product, 2018 - 2030 (USD Million)
  • Table 53 Australia PCR market, by application, 2018 - 2030 (USD Million)
  • Table 54 South Korea PCR market, by type, 2018 - 2030 (USD Million)
  • Table 55 South Korea PCR market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Korea PCR market, by application, 2018 - 2030 (USD Million)
  • Table 57 Latin America PCR market, by Country, 2018 - 2030 (USD Million)
  • Table 58 Latin America PCR market, by type, 2018 - 2030 (USD Million)
  • Table 59 Latin America PCR market, by product, 2018 - 2030 (USD Million)
  • Table 60 Latin America PCR market, by application, 2018 - 2030 (USD Million)
  • Table 61 Brazil PCR market, by type, 2018 - 2030 (USD Million)
  • Table 62 Brazil PCR market, by product, 2018 - 2030 (USD Million)
  • Table 63 Brazil PCR market, by application, 2018 - 2030 (USD Million)
  • Table 64 Mexico PCR market, by type, 2018 - 2030 (USD Million)
  • Table 65 Mexico PCR market, by product, 2018 - 2030 (USD Million)
  • Table 66 Mexico PCR market, by application, 2018 - 2030 (USD Million)
  • Table 67 Argentina PCR market, by type, 2018 - 2030 (USD Million)
  • Table 68 Argentina PCR market, by product, 2018 - 2030 (USD Million)
  • Table 69 Argentina PCR market, by application, 2018 - 2030 (USD Million)
  • Table 70 Middle East & Africa PCR market, by Country, 2018 - 2030 (USD Million)
  • Table 71 Middle East & Africa PCR market, by type, 2018 - 2030 (USD Million)
  • Table 72 Middle East & Africa PCR market, by product, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa PCR market, by application, 2018 - 2030 (USD Million)
  • Table 74 South Africa PCR market, by type, 2018 - 2030 (USD Million)
  • Table 75 South Africa PCR market, by product, 2018 - 2030 (USD Million)
  • Table 76 South Africa PCR market, by application, 2018 - 2030 (USD Million)
  • Table 77 Saudi Arabia PCR market, by type, 2018 - 2030 (USD Million)
  • Table 78 Saudi Arabia PCR market, by product, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia PCR market, by application, 2018 - 2030 (USD Million)
  • Table 80 UAE PCR market, by type, 2018 - 2030 (USD Million)
  • Table 81 UAE PCR market, by product, 2018 - 2030 (USD Million)
  • Table 82 UAE PCR market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 PCR market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 PCR market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook, revenue, 2021, USD Billion
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 PCR market driver impact
  • Fig. 14 PCR market restraint impact
  • Fig. 15 SWOT analysis, by a factor (Political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 PCR market - Unmet needs analysis
  • Fig. 19 Consumer behavior analysis
  • Fig. 20 PCR market: Type outlook and key takeaways
  • Fig. 21 PCR market: Type movement analysis & market share 2021 & 2030
  • Fig. 22 Conventional PCR market estimates and forecast, 2018 - 2030(USD Million)
  • Fig. 23 Others market estimates and forecast, 2018 - 2030(USD Million)
  • Fig. 24 PCR market: Product outlook and key takeaways
  • Fig. 25 PCR market: Product movement analysis & market share 2021 & 2030
  • Fig. 26 Consumables & reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Software & services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 PCR market: Application outlook and key takeaways
  • Fig. 30 PCR market: Application movement analysis & market share 2021 & 2030
  • Fig. 31 Medical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Pathogen testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Oncology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Blood screening market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 36 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Forensics and others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Non-medical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Food market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 PCR market: Regional outlook and key takeaways
  • Fig. 43 Regional outlook, 2021 & 2030
  • Fig. 44 North America
  • Fig. 45 North America. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 U.S.
  • Fig. 47 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Canada
  • Fig. 49 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Europe
  • Fig. 51 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 U.K.
  • Fig. 53 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Germany
  • Fig. 55 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 France
  • Fig. 57 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Italy
  • Fig. 59 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Spain
  • Fig. 61 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Asia Pacific
  • Fig. 63 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Japan
  • Fig. 65 Japan market estimates and forecast, 2018 - 2030(USD Million)
  • Fig. 66 China
  • Fig. 67 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 India
  • Fig. 69 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea
  • Fig. 71 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Australia
  • Fig. 73 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Latin America
  • Fig. 75 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Brazil
  • Fig. 77 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Mexico
  • Fig. 79 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Argentina
  • Fig. 81 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Middle East & Africa
  • Fig. 83 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 South Africa
  • Fig. 85 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Saudi Arabia
  • Fig. 87 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 UAE
  • Fig. 89 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Ansoff Matrix
  • Fig. 91 Market differentiators
  • Fig. 92 Key company market share analysis, 2021
  • Fig. 93 Company market position analysis
  • Fig. 94 Company market position analysis
  • Fig. 95 Competitive dashboard analysis
  • Fig. 96 Regional network map